Hyalusint is a drug intended for the treatment and prevention of diseases and injuries of the musculoskeletal system in horses, dogs and cats. Hyaluronic acid, which is part of the drug, restores the elasticity of articular cartilage and replenishes its defects, stimulates the production of synovial fluid and improves joint mobility.
It is an analogue of the preparations of the French Khionat (Hyonate) and the Czech Bonharen (Bonharen).
For intra-articular and intravenous administration.
Indications for use:
Treatment of lameness in animals, including horses, caused by synovitis and osteoarthritis of non-infectious etiology, acute or chronic synovitis, tendovaginitis, tendinitis and other inflammatory and degenerative diseases of the joints: acute and chronic arthrosis, polyarthrosis, subacute and chronic arthritis, bursitis, osteochondrosis; during the rehabilitation period after surgical interventions on the joints and tendons.
Packaging: 1 x 2 ml ampoule.
Hyalusint is not doping and does not contain substances prohibited by the rules of the Jockey Club and the FEI.